Tips For Scaling mRNA Therapeutics

Scaling up production from research to commercial scale has been a major challenge. Some methods used at small scale cannot be easily scaled up to larger scale. In this segment, Joseph Barberio, VP Technical Operations at Strand Therapeutics and Christian Moreno, Director of Supply Chain Management at Nutcracker Therapeutics share their insight on what’s needed to achieve success in scaling mRNA therapeutics from using high quality materials in the early research stage to planning for the end at the beginning of your processes, and more.